Progenix
by Medtronic Sofamor Danek, Inc.
510(k) K082463
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK082463 | Date10 Nov 2008 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- NUN
- FDA applicant
- Medtronic Sofamor Danek
- Device class
- Class II
- Regulation
- 21 CFR Part 872.3930
- Advisory committee
- Dental
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Progenix Bone Grafting Material, Human Source, is a bone graft substitute classified as a Bone Grafting Material, Human Source under FDA product code NUN. It is designed to act as a bone graft extender and void filler in bony defects or gaps within the skeletal system, including the spine, pelvis, and extremities, without providing mechanical stability to the surgical site. This material is derived from human sources and is intended for use in procedures where natural bone regeneration support is required.
Supplied as a single-use product, Progenix is ready-to-use and intended for surgical applications in dental and orthopedic settings. It is regulated under FDA 510(k) clearance (K082463) and falls under Class II medical devices with special controls. The material is not sterilized for reuse and must be handled in accordance with sterile surgical protocols. No additional regulatory approvals beyond the stated 510(k) clearance are referenced in the available data.
Other devices from Medtronic Sofamor Danek, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the Progenix Bone Grafting Material used for?
Progenix is designed as a bone graft extender and void filler to support natural bone regeneration in bony defects or gaps within the skeletal system. It is specifically intended for use in dental and orthopedic procedures—such as spinal, pelvic, or extremity surgeries—where additional bone support is required but mechanical stability is not provided by the material itself. It helps bridge gaps where natural bone healing may otherwise be insufficient.
How is the Progenix Bone Grafting Material supplied and prepared for use?
Progenix is supplied as a single-use, ready-to-use product, meaning it does not require additional preparation or sterilization by the clinician before surgical application. It is intended to be handled and applied under sterile surgical protocols, as it is not sterilized for reuse. The packaging ensures sterility for one-time surgical use only.
Is Progenix derived from human sources, and what does that mean for its use?
Yes, Progenix is derived from human sources, classified as a Bone Grafting Material under FDA product code NUN. This means it is processed from human tissue to provide biocompatible support for bone regeneration. Its human origin ensures compatibility with the patient’s own biological processes, but it does not replace structural support—it acts as an extender to aid natural healing in bony defects.
Can Progenix be reused after a single surgical procedure?
No, Progenix is explicitly designed for single-use only. The material is not sterilized for reuse, and its packaging is intended to maintain sterility for one surgical application. Reusing it would violate sterile surgical protocols and could compromise patient safety. Always follow the manufacturer’s instructions for single-use disposal after use.
What regulatory clearance does Progenix hold, and how does that affect its use?
Progenix holds FDA 510(k) clearance (K082463) under the classification of Bone Grafting Material, Human Source, and is categorized as a Class II medical device with special controls. This clearance confirms it meets FDA standards for safety and effectiveness as a bone graft extender. Clinicians should adhere to the approved labeling and surgical guidelines provided by Medtronic Sofamor Danek to ensure compliance with regulatory requirements.